Growing community of inventors

Norristown, PA, United States of America

Marco Pagnoni

Average Co-Inventor Count = 4.35

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 8

Marco PagnoniKenneth Lyle Clark (5 patents)Marco PagnoniKun Guo (5 patents)Marco PagnoniYuri D Ivashchenko (4 patents)Marco PagnoniGeorge H Searfoss, Iii (2 patents)Marco PagnoniYuri Ivashchenko (1 patent)Marco PagnoniMarco Pagnoni (5 patents)Kenneth Lyle ClarkKenneth Lyle Clark (16 patents)Kun GuoKun Guo (6 patents)Yuri D IvashchenkoYuri D Ivashchenko (5 patents)George H Searfoss, IiiGeorge H Searfoss, Iii (3 patents)Yuri IvashchenkoYuri Ivashchenko (4 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Aventis Pharmaceuticals Inc. (3 from 207 patents)

2. Sanofi-aventis (1 from 389 patents)

3. Centelion Sas (1 from 2 patents)


5 patents:

1. 7989584 - AKT nucleic acids, polypeptides, and uses thereof

2. 7662628 - Human Akt3 nucleic acid and uses thereof

3. 7332593 - Variants of TRAF2 which act as an inhibitor of TNF-alpha (TNFα) signaling pathway

4. 6998475 - Variants of traf2 which act as an inhibitor of tnf-alpha (tnfα) signaling pathway

5. 6881555 - AKT nucleic acids, polypeptides, and uses thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/8/2025
Loading…